Rosti, Gianantonio http://orcid.org/0000-0002-0310-4206
Brümmendorf, Tim H. http://orcid.org/0000-0002-9677-3723
Gjertsen, Björn T.
Giraldo-Castellano, Pilar
Castagnetti, Fausto http://orcid.org/0000-0002-0602-2628
Gambacorti-Passerini, Carlo http://orcid.org/0000-0001-6058-515X
Ernst, Thomas http://orcid.org/0000-0003-2147-489X
Zhao, Huadong
Kuttschreuter, Luke http://orcid.org/0000-0002-3632-8740
Purcell, Simon
Giles, Francis J.
Hochhaus, Andreas http://orcid.org/0000-0003-0626-0834
Funding for this research was provided by:
Pfizer
Article History
Received: 25 July 2023
Revised: 24 October 2023
Accepted: 1 November 2023
First Online: 25 November 2023
Competing interests
: GR received research support from Pfizer and served on the speaker bureau for Bristol Myers Squibb, Incyte, Novartis, and Pfizer. THB provides consultancy to Janssen, Merck, Novartis, Pfizer, and Takeda, and received research support from Novartis and Pfizer. BTG provides consultancy to BerGenBio, Novartis, Pfizer, and Sanofi, received research support from Pfizer, and has stock ownership in Alden Cancer Therapy AS and KinN Therapeutics AS. PG-C received research support from Bristol Myers Squibb and Pfizer. FC provides consultancy to and received honoraria from Bristol Myers Squibb, Incyte, Novartis, and Pfizer, and received research support from Pfizer. CG-P provides consultancy to Bristol Myers Squibb and received honoraria and research support from Pfizer. TE, no relationships to disclose. HZ, LK, and SP are employees of Pfizer. FJG provided consultancy to Actuate Therapeutics Inc, provided expert testimony to Novartis, and received research support from Pfizer. AH received research support from Bristol Myers Squibb, Incyte, Novartis, and Pfizer.